Abstract
Polyamines are involved in the development of breast cancer. We assayed polyamines in erythrocytes, urines, and breast tissues (tumor tissue and histologically normal breast tissue close to the tumor) of patients with invasive breast cancer (n=174) and benign breast disease (n=71, used as controls). Polyamine levels in red blood cells and urine were similar to the polyamine concentrations found in healthy subjects, and thus cannot be used as diagnostic markers of breast cancer. In cancer tissue, polyamines were significantly increased in comparison with the polyamine concentrations in controls, and were correlated to the tumor aggressiveness as evaluated by histological grade and Ki-67 proliferative index. On the other hand, correlation was found between polyamine levels in the tumor and the status of the hormone receptors. In the mammary tissue close to the cancer, polyamines dramatically decreased in comparison with the polyamine levels of tissue samples removed around the histologically proven benign tumors. The changes of the polyamine concentrations in the histologically normal breast tissue in the vicinity of the cancer could play a role in the cancer development and need further studies, especially if polyamines are considered as a potential therapeutic target in breastcancer.
Similar content being viewed by others
References
Pegg AE, McCann PP: Polyamine metabolism and function: a brief review. Am J Physiol 243: 212–221, 1982
Jänne J, Pös H, Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241–293, 1978
Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988
Kendra KL, Katzellenbogen BS: An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone levels by estrogen and antiestrogen. J Steroid Biochem 28: 123–128, 1987
Thomas T, Kiang DT: Additive growth-inhibitory effect of DL-α-adifluoromethylornithine and antiestrogens on the MCF-7 breast cancer cell line. Biochem Biophys Res Commun 148: 1338–1345, 1987
Glikman P, Manni A, Demers L, Bartholomew M: Polyamine involvement in the growth of hormone-responsive and-resistant human breast cancer cells in culture. Cancer Res 49: 1371–1376, 1989
Manni A, Badger B, Martel J, Demers L: Role of polyamines on the growth of hormone-responsive and-resistant human breast cancer cells in nude mice. Cancer Lett 66: 1–9, 1992
Kremmer T, Palyi I, Daubner D, Boldizsar M, Vincze B, Paulik E, Sugar J, Pokorny E, Tury E: Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Anticancer Res 11: 1807–1814, 1991
Seiler N, Sarhan S, Graufel C, Jones R, Knodgen B, Moulinoux JP: Endogenous and exogenous polyamines in support to tumor growth. Cancer Res 50: 5077–5083, 1990
Levêque J, Burtin F, Catros-Quemener V, Havouis R, Moulinoux J-P: The gastrointestinal polyamine source depletion enhances the DFMO induced polyamine depletion in MCF-7 human breast cancer in vivo. Anticancer Res 18: 2663–2668, 1998
Azzopardi JG: Histological typing of breast tumors. WHO 1968 International Histological Classification of tumors. Geneva, 1981. Ann Pathol 2: 91–105, 1982
Union Internationale Contre le Cancer (UICC): Tumeurs du sein. In: UICC (ed) TNM classification des tumeurs malignes. Springer Verlag, Paris, 1988, pp 99–106
Bloom J, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 357–377, 1957
Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M: Prognostic value of histological grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64: 1914–1921, 1989
Hrushe WJM, Merdink J, Abdel-Monem A: Circadian rhythmicity of polyamine urinary excretion: Cancer Res 43: 3944–3947, 1983
Seiler N: Separation of ion pairs of polyamines and related compounds on reversed phases. In: Kabra PM, Marton LJ (eds) Clinical Liquid Chromatography: Analysis of Endogenous Compounds. CRC Press, London, 1993, pp 179–187
Shinpo K, Fujita K, Maruta K, Teradaira R, Nagatsu T: Comparative measurements of urinary polyamines in early morning and 24-hour urine specimens. Clin Chim Acta 131: 143–148, 1983
Pöyhönen MJ, Uusitalo UM, Kari A, Takala JA, Alakuijala LA, Eloranta TO: Urinary excretion of polyamines: importance of circadian rhythm, age, sex, menstrual cycle, weight, and creatinine excretion. Am J Clin Nutr 52: 746–751, 1990
Seiler N, Bolkenius FN, Rennert OM: Interconversion, catabolism and elimination of the polyamines. Med Biol 59: 334–346, 1981
Suh JW, Lee SH, Chung BC, Park J: Urinary polyamine evaluation for effective diagnosis of various cancers. J Chromatog B 688, 179–186, 1997
Cipolla B, Moulinoux JP, Quemener V, Havouis R, Martin L, Guillé F, Lobel B: Erythrocyte polyamine levels in human prostatic carcinoma. J Urol 144: 1164–1166, 1990
Moulinoux JP, Quemener V, Le Calvé ML, Chatel M, Darcel F: Polyamines in human brain tumors: A correlative study between tumor, cerebrospinal fluid and red blood cell free polyamine levels. J Neuro-Oncol 2: 153–158, 1984
Löser C, Fölsch UR, Paprotny C, Creutzfeldt W: Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer 65: 958–966, 1990
Waalkes TP, Gehrke CW, Tormey DC, Zumwalt RW, Hueser IN, Kuo KC, Lakings DB, Ahmann DL, Moertel CG: Urinary excretion of polyamines by patients with advanced malignancy. Cancer Chemother Rep 59: 1103–1116, 1975
Quemener V, Le Gall E, Edan C, Moulinoux JP: Red blood cell polyamine levels in children with acute leukemia: their clinical interest in disease staging and monitoring of therapy efficiency. Cancer J 4: 174–179, 1986
Kingnorth AN, Wallace HM, Bundred NJ, Dixon JMJ: Polyamines in breast cancer. Br J Surg 71: 352–356,1984
Glikman P, Vegh I, Pollina MA, Mosto AH, Levy CM: Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 60: 2237–2243,1987
Manni A, Mauger D, Gimotty P, Badger B: Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res 2: 1901–1906, 1996
Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55–91, 1995
Manni A, Badger B, Lynch J, Glikman P, Demers L: Hormonal control of polyamine pools in experimental breast cancer in vivo: correlation with estrogen and progesterone receptor levels. Breast Cancer Res Treat 14: 227–234, 1989
Thomas T, Thomas T: Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res Treat 9: 189–201, 1993
Manni A, Grove R, Kunzelman S, Aldaz M: Involvement of the polyamine pathway in breast cancer progression. Cancer Lett 92: 49–57, 1995
Lu B, Liang X, Scott GK, Chang CH, Baldwin MA, Thomas T, Benz CC: Polyamine inhibition of estrogen receptor (ER) DNA-binding and ligand-binding functions. Breast Cancer Res Treat 48: 243–257, 1998
Chanda R, Ganguly AK: Polyamines in relation to human breast cancer, rectal and squamous cell carcinoma. Cancer Let 39: 311–318, 1988
Persson L, Rosengren E: Increased formation of N1-acetylspermidine in human breast cancer. Cancer Let 45: 83–86, 1989
Seiler N, Delcros JG, Moulinoux JP: Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 28: 843–861, 1996
Seiler N: Formation, catabolism and properties of the natural polyamines. In: Carter C (ed) The Neuropharmacology of Polyamines. Academic Press, London, 1994, pp 1–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levêque, J., Levêque, J., Foucher, F. et al. Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers. Breast Cancer Res Treat 60, 99–105 (2000). https://doi.org/10.1023/A:1006319818530
Issue Date:
DOI: https://doi.org/10.1023/A:1006319818530